Mr Jai Seth has co-authored over 40 peer-reviewed publications in urology and neuro-urology. Highlights include first-author work in BJU International on nerve growth factor as a potential urinary biomarker for overactive bladder, a Journal of Urology editorial on the timing of reconstructive surgery in neuropathic bladder, and a chapter on the neurological organisation of micturition in the Handbook of Clinical Neurology.
2023
Wong K, Kinsella N, Mr Jai Seth, Nicol D, Cahill D, Kasivisvanathan R, Withington J, Moghul M, Moss CL, Van Hemelrijck M, Giorgakoudi K, Cottrell C, Yates E, Khoo V, James ND.
BMJ Open 13(10): e076621 (2023).
Predictors for adverse events following intravesical botulinum toxin injections in men
Ribeiro L, Leung LY, Tan N, Low Z-Y, Nagarajah M, Ahmed G, Carey M, Sabbagh S, Sharma D, Mr Jai Seth.
Neurourology and Urodynamics 42(7): 1499-1505 (2023).
Senior authorDOI: 10.1002/nau.25230PubMed: 37386824
2020
Pelvic plexiform neurofibromatosis presenting with genital numbness
Leung LY, Shah S, Mr Jai Seth, Pakzad M, Afridi S, Panicker JN.
Practical Neurology 20(2): 165-166 (2020).
Co-authorDOI: 10.1136/practneurol-2019-002375PubMed: 31818923
Tudor KI, Mr Jai Seth, Liechti MD, Ochulor J, Gonzales G, Haslam C, Fox Z, Pakzad M, Panicker JN.
Clinical Autonomic Research 30(1): 61-67 (2020).
2019
Nguyen L, Leung LY, Walker R, Nitkunan T, Sharma D, Mr Jai Seth.
Neurourology and Urodynamics 38(8): 2060-2069 (2019).
Senior authorDOI: 10.1002/nau.24143PubMed: 31432568
2018
Urethral Sphincter Injection of Botulinum Toxin A: A Review of Its Application and Outcomes
Mr Jai Seth, Rintoul-Hoad S, Sahai A.
Lower Urinary Tract Symptoms 10(2): 109-115 (2018).
First authorDOI: 10.1111/luts.12163PubMed: 28224714
2016
Urolithiasis following urinary diversion
Mr Jai Seth, Promponas J, Hadjipavlou M, Anjum F, Sriprasad S.
Urolithiasis 44(5): 383-388 (2016).
First authorDOI: 10.1007/s00240-016-0880-yPubMed: 27114354
Nocturia in Patients With Parkinson's Disease
Smith M, Mr Jai Seth, Batla A, Hofereiter J, Bhatia KP, Panicker JN.
Movement Disorders Clinical Practice 3(2): 168-172 (2016).
2013
The neurological organization of micturition
Mr Jai Seth, Panicker JN, Fowler CJ.
Handbook of Clinical Neurology 117: 111-117 (2013).
First authorDOI: 10.1016/B978-0-444-53491-0.00010-9PubMed: 24095120
Botulinum toxin—what urologic uses does the data support?
Mr Jai Seth, Khan MS, Dasgupta P, Sahai A.
Current Urology Reports 14(3): 227-234 (2013).
First authorDOI: 10.1007/s11934-013-0326-9PubMed: 23625366
Urinary retention for the neurologist
Smith MD, Mr Jai Seth, Fowler CJ, Miller RF, Panicker JN.
Practical Neurology 13(5): 288-291 (2013).
Co-authorDOI: 10.1136/practneurol-2012-000478PubMed: 23542501
Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Mr Jai Seth, Sahai A, Khan MS, van der Aa F, De Ridder D, Panicker JN, Dasgupta P, Fowler CJ.
BJU International 111(3): 372-380 (2013).
First authorDOI: 10.1111/j.1464-410X.2012.11672.xPubMed: 23444927
C-fibre sensory nerves — not so silent as we think?
Panicker JN, Mr Jai Seth.
BJU International 112(1): 129-130 (2013).
2012
Mr Jai Seth, Sahai A, Dasgupta P.
InnovAiT (Journal of the Royal College of General Practitioners' training journal) (2012).
First authorDOI: 10.1093/innovait/ins066
2011
Timing of reconstructive surgery in patients with neuropathic bladder
Mr Jai Seth, Panicker JN.
Journal of Urology 185(6): 2014-2015 (2011).
First authorDOI: 10.1016/j.juro.2011.03.061PubMed: 21496843
Press and media
Dr. Seth weighs in on onabotulinumtoxinA injections in patients with complex medical backgrounds
Urology Times
Interview and summary on intravesical onabotulinumtoxinA safety in medically complex and anticoagulated patients — with <1% bleeding risk in studied cohort.
Dr. Seth advises individualized counseling for patients using Botox treatments and blood thinners
Urology Times
Clinical commentary on tailoring bladder Botox decision-making for patients on anticoagulation.
Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners
Urology Times
Risk framing for bladder Botox in anticoagulated patients.
Bleeding risk in patients using Botox treatments and blood thinners
Urology Times
Series piece on bleeding-risk assessment in bladder Botox + anticoagulants.